Jasper Therapeutics (JSPR) Other Non Operating Income (2020 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Other Non Operating Income of -$29000.0 for Q4 2025, down 211.54% year-over-year from $26000.0 in Q4 2024, and up 98.56% quarter-over-quarter from -$2.0 million in Q3 2025.
Jasper Therapeutics (JSPR) Other Non Operating Income (2020 - 2025) Analysis & Trends
Jasper Therapeutics' Other Non Operating Income history runs 5 years deep, the most recent figure standing at -$29000.0 for Q4 2025.
- In Q4 2025, Other Non Operating Income fell 211.54% year-over-year to -$29000.0; the TTM figure through Dec 2025 stood at -$2.2 million (down 2385.23% YoY), while the FY2025 annual figure was -$2.2 million, down 2385.23% from the prior year.
- Other Non Operating Income for Q4 2025 stood at -$29000.0, up from -$2.0 million in the prior quarter.
- The five-year high for Other Non Operating Income was $3.5 million in Q1 2021, with the low at -$3.6 million in Q4 2021.
- The 4-year median for Other Non Operating Income is -$40000.0 (2024), against an average of -$186115.5.
- The sharpest annual moves came in 2021 and 2025: Other Non Operating Income jumped 976.08% in 2021, then sank 6184.38% in 2025.
- Jasper Therapeutics' Other Non Operating Income stood at -$3.6 million in 2021, then jumped by 96.7% to -$118000.0 in 2023, then surged by 122.03% to $26000.0 in 2024, then slumped by 211.54% to -$29000.0 in 2025.
- Business Quant data shows JSPR's Other Non Operating Income at -$29000.0 in Q4 2025, -$2.0 million in Q3 2025, and -$84000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Jasper Therapeutics | 20.08 Mn | 20.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | -2.01 Mn |
| Jun 30, 2025 | -84,000.00 |
| Mar 31, 2025 | -63,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | -32,000.00 |
| Jun 30, 2024 | -40,000.00 |
| Mar 31, 2024 | -42,000.00 |
| Dec 31, 2023 | -118,000.00 |
| Sep 30, 2023 | 51,000.00 |
| Dec 31, 2021 | -3.58 Mn |
| Jun 30, 2021 | 2,498.00 |
| Mar 31, 2021 | 3.50 Mn |
| Dec 31, 2020 | 4.01 Mn |
| Sep 30, 2020 | 4.71 Mn |
| Jun 30, 2020 | 44,307.00 |
| Mar 31, 2020 | 325,348.00 |